BridgeMD
The Pancreatic Enzymes after Gastrectomy Trial
EU CTIS ID: 2022-501944-14-00
What this study is testing
Can enzyme supplementation with every meal after gastrectomy lead to improved disease specific quality of life at 6 months after gastrectomy?
- Therapeutic confirmatory (Phase III)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- • Gastrectomy (total and partial) • Age 18 or older
You likely can't join if
- • Indication for pancreas enzyme therapy • Gastrectomy with palliative intention • UICC (Union for International Cancer Control) Stage IV gastric malignancy • Malnutrition of other aetiology • Life expectancy < 12 months • Known lactose intolerance • Known hereditary galactose intolerance • Patients on alpha-glucosidase inhibitors (AGIs) • Acute pancreatitis • Acute episode of chronic pancreatitis • Known hypersensitivity to moulds (mould allergy) or any other ingredient of NORTASE®
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18-64 years, 65+ years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.